NO20070832L - Farmasoytiske preparat av piperazinderivater. - Google Patents

Farmasoytiske preparat av piperazinderivater.

Info

Publication number
NO20070832L
NO20070832L NO20070832A NO20070832A NO20070832L NO 20070832 L NO20070832 L NO 20070832L NO 20070832 A NO20070832 A NO 20070832A NO 20070832 A NO20070832 A NO 20070832A NO 20070832 L NO20070832 L NO 20070832L
Authority
NO
Norway
Prior art keywords
pharmaceutical preparations
piperazine derivatives
preservatives
family
composition containing
Prior art date
Application number
NO20070832A
Other languages
English (en)
Other versions
NO337768B1 (no
Inventor
Michel Deleers
Domenico Fanara
Jean Scouvart
Claire Poulain
Original Assignee
Ucb Farchim Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34925743&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20070832(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ucb Farchim Sa filed Critical Ucb Farchim Sa
Publication of NO20070832L publication Critical patent/NO20070832L/no
Publication of NO337768B1 publication Critical patent/NO337768B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Foreliggende oppfinnelse angår et væskepreparat inneholdende en aktiv substans tilhørende familien av substituerte benzhydrylpiperaziner med reduserte mengder av konserveringsmidler.
NO20070832A 2004-07-14 2007-02-13 Væskeformig, farmasøytisk preparat av piperazinderivater, og minst ett konserveringsmiddel av parahydroksybenzoatestere NO337768B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04016519 2004-07-14
PCT/EP2005/007340 WO2006005507A2 (en) 2004-07-14 2005-07-07 Pharmaceutical composition of piperazine derivatives

Publications (2)

Publication Number Publication Date
NO20070832L true NO20070832L (no) 2007-02-13
NO337768B1 NO337768B1 (no) 2016-06-20

Family

ID=34925743

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070832A NO337768B1 (no) 2004-07-14 2007-02-13 Væskeformig, farmasøytisk preparat av piperazinderivater, og minst ett konserveringsmiddel av parahydroksybenzoatestere

Country Status (25)

Country Link
US (1) US8633194B2 (no)
EP (1) EP1768649B1 (no)
JP (1) JP4902875B2 (no)
KR (1) KR101185612B1 (no)
CN (1) CN100508981C (no)
AR (1) AR049846A1 (no)
AT (1) ATE443512T1 (no)
AU (1) AU2005261953B2 (no)
BR (1) BRPI0513257C1 (no)
CA (1) CA2573662A1 (no)
CY (1) CY1109670T1 (no)
DE (1) DE602005016802D1 (no)
EA (1) EA012463B1 (no)
ES (1) ES2332462T3 (no)
IL (1) IL180010A0 (no)
MX (1) MX2007000230A (no)
MY (1) MY149403A (no)
NO (1) NO337768B1 (no)
NZ (1) NZ552182A (no)
PE (1) PE20060484A1 (no)
PL (1) PL1768649T3 (no)
PT (1) PT1768649E (no)
TW (1) TWI304339B (no)
WO (1) WO2006005507A2 (no)
ZA (1) ZA200700939B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3943069T (pt) 2009-03-17 2025-02-21 Nicox Ophthalmics Inc Formulações oftálmicas de cetirizina e métodos de utilização
US8569273B2 (en) 2009-03-17 2013-10-29 Aciex Therapeutics, Inc. Ophthalmic formulations of cetirizine and methods of use
TWI503122B (zh) * 2012-02-15 2015-10-11 Taiho Pharmaceutical Co Ltd Oral administration of pharmaceutical compositions
KR102155836B1 (ko) 2013-02-22 2020-09-14 삼성전자주식회사 터치 스크린 상에서 객체 디스플레이를 제어하는 휴대 단말 및 방법
US11241426B2 (en) 2017-02-13 2022-02-08 Nitto Medic Co., Ltd. Aqueous composition for ophthalmic or nasal administration
CN113712907A (zh) * 2020-05-25 2021-11-30 南京帝昌医药科技有限公司 一种盐酸左西替利嗪滴眼液组合物及其制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4255358A (en) * 1978-03-13 1981-03-10 The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Process for the production of hexanitrostilbene
NO155805C (no) 1981-02-06 1987-06-10 Ucb Sa Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-(4-(difenylmethyl)-1-piperazinyl)-eddiksyrer og deres amider og ikke-toksiske salter.
NZ215069A (en) * 1985-03-01 1988-06-30 Reckitt & Colmann Prod Ltd Pharmaceutical composition with histamine h 2 -receptor antagonist
US4728509A (en) * 1985-08-19 1988-03-01 Takeda Chemical Industries, Ltd. Aqueous liquid preparation
JP3278192B2 (ja) * 1992-04-03 2002-04-30 ロート製薬株式会社 徐放性液剤
TW401300B (en) 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
US5504113A (en) * 1994-03-02 1996-04-02 Allergan, Inc. Enhancement of benzalkonium chloride preservative activity in formulations containing an incompatible drug
AU3609795A (en) * 1994-10-10 1996-05-02 Novartis Ag Ophthalmic and aural compositions containing diclofenac potassium
TW536403B (en) * 1997-03-24 2003-06-11 Glaxo Group Ltd An ethanol and ethylenediaminetetraacetic acid free pharmaceutical composition comprising lamivudine and exhibiting antimicrobial preservative efficacy
US6432961B1 (en) * 1998-08-18 2002-08-13 Ucb S.A. Method for preventing the onset of asthma
AUPQ419099A0 (en) * 1999-11-23 1999-12-16 Ko, Thomas Sai Ying Novel compositions and methods
DE10007203A1 (de) * 2000-02-17 2001-08-23 Asta Medica Ag Neue Kombination nichtsedierender Antihistaminika mit Substanzen, die die Leukotrienwirkung beeinflussen, zur Behandlung der Rhinitis/Konjunktivitis
US6258814B1 (en) * 2000-10-13 2001-07-10 Schering Corporation Method of using cetirizine and pharmaceutical compositions containing the same for inducing sleep
UA80393C2 (uk) * 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
AU2002221854A1 (en) 2000-12-15 2002-06-24 U C B, S.A. Use of cetirizine or efletirizine for preventing urticaria
US6869618B2 (en) * 2001-04-10 2005-03-22 Kiel Laboratories, Inc. Process for preparing tannate liquid and semi-solid dosage forms
DK1531822T3 (da) * 2002-06-12 2009-12-07 Chemocentryx Inc 1-aryl-4-substituerede piperazin derivater til anvendelse som CCR1 antagonister til behandlingen af inflammation og immunforstyrrelser
WO2004004705A2 (en) 2002-07-03 2004-01-15 Shannon Biotechnology Ltd Pharmaceutical formulations for preparing drink products
CA2506965A1 (en) 2002-12-03 2004-06-17 Ucb Farchim S.A. Use of levocetirizine for the treatment of persistent allergic rhinitis
US20050255154A1 (en) 2004-05-11 2005-11-17 Lena Pereswetoff-Morath Method and composition for treating rhinitis
US20090137645A1 (en) * 2007-10-31 2009-05-28 Midlothian Laboratories, Llc Shelf-Stable Famotidine Granulates for Oral Suspensions

Also Published As

Publication number Publication date
CN100508981C (zh) 2009-07-08
DE602005016802D1 (de) 2009-11-05
IL180010A0 (en) 2007-05-15
CY1109670T1 (el) 2014-08-13
WO2006005507A2 (en) 2006-01-19
PE20060484A1 (es) 2006-07-06
BRPI0513257A (pt) 2008-04-29
NZ552182A (en) 2010-07-30
CA2573662A1 (en) 2006-01-19
ATE443512T1 (de) 2009-10-15
ES2332462T3 (es) 2010-02-05
EA012463B1 (ru) 2009-10-30
PL1768649T3 (pl) 2010-02-26
HK1103958A1 (zh) 2008-01-04
BRPI0513257B1 (pt) 2018-05-29
EA200700067A1 (ru) 2007-08-31
JP2008505949A (ja) 2008-02-28
JP4902875B2 (ja) 2012-03-21
BRPI0513257C1 (pt) 2021-05-25
EP1768649B1 (en) 2009-09-23
TWI304339B (en) 2008-12-21
EP1768649A2 (en) 2007-04-04
TW200605892A (en) 2006-02-16
NO337768B1 (no) 2016-06-20
ZA200700939B (en) 2008-08-27
MY149403A (en) 2013-08-30
MX2007000230A (es) 2007-03-30
US8633194B2 (en) 2014-01-21
PT1768649E (pt) 2009-11-13
AU2005261953B2 (en) 2010-06-03
KR20070043841A (ko) 2007-04-25
WO2006005507A8 (en) 2006-12-07
WO2006005507A3 (en) 2006-04-27
KR101185612B1 (ko) 2012-09-24
AU2005261953A1 (en) 2006-01-19
CN1984641A (zh) 2007-06-20
AR049846A1 (es) 2006-09-06
US20070275974A1 (en) 2007-11-29

Similar Documents

Publication Publication Date Title
ECSP20027480A (es) Indolil alquil amino derivados sustituidos como nuevos inhibidores de la histona desacetilasa
BRPI0821004A8 (pt) Composto derivado de aminopirazol, composição farmacêutica que o contem e uso deste
MA32508B1 (fr) Composes organiques
EA200870216A1 (ru) Амидо соединения и их применение в качестве лекарственных средств
SV2011003786A (es) Compuestos quimicos 251
EA200700117A1 (ru) N-замещенные пиперидины и их применение в качестве фармацевтических препаратов
DE60334773D1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
EA201170772A1 (ru) Органические соединения
UY30316A1 (es) Derivados sustituidos de benzamidas, nicotinamidas, propanamidas, acetamidas y carboxamidas n-(2-(piperidin-1-ilmetil)ciclohexil)sustituidas, procesos de preparacion, composiciones conteniéndolos y aplicaciones
EA200702498A1 (ru) N-(пиридин-2-ил)сульфонамидные производные
EA201170703A1 (ru) Производные адамантилбензамида
BRPI0416752B8 (pt) composição farmacêutica, uso de um ou mais compostos, e, compostos
EA200700096A1 (ru) Производные 2-карбамид-4-фенилтиазола, способ их получения и их применение в терапии
BRPI0508579A (pt) composto, composição farmacêutica, e, uso de um composto
ECSP088689A (es) NOVEDOSAS 11ß-HIDROXIANDROSTA-4-EN-3-ONAS
EA201170512A1 (ru) Композиция для перорального введения
CY1109366T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης
DE602006006712D1 (de) Thiazolylpiperidin-derivate nützlich als h3 rezeptor modulatoren
BRPI0717369A2 (pt) Composto, medicamento, composição farmacêutica que o contém e uso do composto.
BRPI0311189B8 (pt) composições farmacêuticas contendo polimorfo a de flibanserin, bem como seu uso
BRPI0922870A2 (pt) uso de ao menos um composto da fórmula i, do compsoto ohod ou seus derivados farmaceuticamente aceitáveis, do composto na-ohod, composição farmacêutica e/ou nutracêutica e método cosmético
BRPI0606606A2 (pt) composições estáveis contendo prostaglandina
BR112012009311A2 (pt) composto, composição farmacêutica, e, uso do composto
NO20055631L (no) Doseringsform inneholdende pantoprazol som aktiv ingrediens
BRPI0720684A2 (pt) composto, medicamento, composição farmacêutica que contém e uso do composto